Company Filing History:
Years Active: 2004-2008
Title: Militza K Ausmanas: Innovator in Hormone Replacement Therapy
Introduction
Militza K Ausmanas is a notable inventor based in Lake Forest, Illinois. She has made significant contributions to the field of hormone replacement therapy, holding three patents to her name. Her innovative approaches have the potential to improve the quality of life for many individuals undergoing hormone therapy.
Latest Patents
Among her latest patents is a groundbreaking method for low dose estrogen interrupted hormone replacement therapy. This therapy comprises a series of daily doses of a pharmaceutical preparation, administered continuously and consecutively in alternating phases. The first phase features a dominant estrogenic activity, providing three daily doses equivalent to about 1 mg per day of 17β-estradiol. The second phase includes a combination of estrogenic activity equivalent to about 1 mg per day of 17β-estradiol and progestogenic activity equivalent to about 90 µg per day of norgestimate. This innovative approach aims to optimize hormone replacement therapy for patients.
Career Highlights
Throughout her career, Militza has worked with various organizations, including Duramed Pharmaceuticals, Inc. Her experience in the pharmaceutical industry has equipped her with the knowledge and skills necessary to develop effective hormone therapies.
Collaborations
Militza has collaborated with notable professionals in her field, including Robert Frederic Casper and Gary A Shangold. These collaborations have contributed to her success and the advancement of her innovative therapies.
Conclusion
Militza K Ausmanas is a pioneering inventor whose work in hormone replacement therapy has the potential to transform patient care. Her patents reflect her commitment to improving health outcomes through innovative solutions.